Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia

References

• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166–78. doi: 10.1056/NEJMra052603
   PubMed Web of Science ®Google Scholar
• Ayala F, Dewar R, Kieran M, Kalluri R. Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia. 2009;23(12):2233–41. doi: 10.1038/leu.2009.175
   PubMed Web of Science ®Google Scholar
• Iwamoto S, Mihara K, Downing JR, Pui CH, Campana D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J Clin Invest. 2007;117(4):1049–57. doi: 10.1172/JCI30235
   PubMed Web of Science ®Google Scholar
• Tait CR, Jones PF. Angiopoietins in tumours: the angiogenic switch. J Pathol. 2004;204(1):1–10. doi: 10.1002/path.1618
   PubMed Web of Science ®Google Scholar
• Fagiani E, Christofori G. Angiopoietins in angiogenesis. Cancer Lett. 2013;328(1):18–26. doi: 10.1016/j.canlet.2012.08.018
   PubMed Web of Science ®Google Scholar
• Xu Y, Yu Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biochem. 2001;276(37):34990–8.
   Google Scholar
• Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Cir Res. 2000;86(1):24–9. doi: 10.1161/01.RES.86.1.24
   PubMed Web of Science ®Google Scholar
• Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 1996;87(7):1161–9. doi: 10.1016/S0092-8674(00)81812-7
   PubMed Web of Science ®Google Scholar
• Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149–61. doi: 10.1016/j.cell.2004.07.004
   PubMed Web of Science ®Google Scholar
• Ichihara E, Kaneda K, Saito Y, Yamakawa N, Morishita K. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells. Biochem Bio Res Co. 2011;416(3–4):239–45. doi: 10.1016/j.bbrc.2011.10.061
   PubMed Web of Science ®Google Scholar
• Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biochem. 1999;274(22):15732–9.
   Google Scholar
• Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Cir Res. 1998;83(8):852–9. doi: 10.1161/01.RES.83.8.852
   PubMed Web of Science ®Google Scholar
• Burger JA, Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia. 2009;23(1):43–52. doi: 10.1038/leu.2008.299
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Cooper S, Kohli L, Hangoc G, Lee Y, Mantel C, et al. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J Immunol. 2003;170(1):421–9. doi: 10.4049/jimmunol.170.1.421
   PubMed Web of Science ®Google Scholar
• Tavor S, Petit I. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia? Semin Cancer Biol. 2010;20(3):178–85. doi: 10.1016/j.semcancer.2010.07.001
   PubMed Web of Science ®Google Scholar
• Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335–48. doi: 10.1016/j.cell.2005.02.034
   PubMed Web of Science ®Google Scholar
• Hoh BL, Hosaka K, Downes DP, Nowicki KW, Wilmer EN, Velat GJ, et al. Stromal cell-derived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls. J Neurosurg. 2014;120(1):73–86. doi: 10.3171/2013.9.JNS122074
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Marquez LA, Dobrowsky A, Ratajczak MZ, Cabuhat ML. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol. 2000;28(11):1274–85. doi: 10.1016/S0301-472X(00)00532-4
   PubMed Web of Science ®Google Scholar
• Li KC, Huang YH, Ho CY, Chu CY, Cha ST, Tsai HH, et al. The role of IL-8 in the SDF-1alpha/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma. Oral Oncol. 2012;48(6):507–15. doi: 10.1016/j.oraloncology.2012.01.006
   PubMed Web of Science ®Google Scholar
• Yetgin S, Yenicesu I, Cetin M, Tuncer M. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. Leukemia Lymphoma. 2001;42(1–2):83–8. doi: 10.3109/10428190109097679
   PubMed Web of Science ®Google Scholar
• Schneider P, Vasse M, Legrand E, Callat MP, Vannier JP. Have urinary levels of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, a prognostic value in childhood acute lymphoblastic leukaemia? Br J Haematol. 2003;122(1):163–4. doi: 10.1046/j.1365-2141.2003.04395_4.x
   PubMed Web of Science ®Google Scholar
• Lyu CJ, Rha SY, Won SC. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia. Yonsei Med J. 2007;48(2):171–5. doi: 10.3349/ymj.2007.48.2.171
   PubMed Web of Science ®Google Scholar
• van den Berk LC, van der Veer A, Willemse ME, Theeuwes MJ, Luijendijk MW, Tong WH, et al. Disturbed CXCR4/CXCL12 axis in paediatric precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2014;166(2):240–9. doi: 10.1111/bjh.12883
   PubMed Web of Science ®Google Scholar
• Flohr T, Schrauder A, Cazzaniga G, Panzer-Grumayer R, van der Velden V, Fischer S, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia. 2008;22(4):771–82. doi: 10.1038/leu.2008.5
   PubMed Web of Science ®Google Scholar
• Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA. 2005;293(12):1485–9. doi: 10.1001/jama.293.12.1485
   PubMed Web of Science ®Google Scholar
• Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grumayer R, Moricke A, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010;115(16):3206–14. doi: 10.1182/blood-2009-10-248146
   PubMed Web of Science ®Google Scholar
• Sbaa-Ketata E, Vasse M, Lenormand B, Schneider P, Soria C, Vannier JP. Fibronectin increases the migration induced by stromal cell-derived factor-1 alpha (SDF-1 alpha) in pre-B acute lymphoblastic leukemia cells. Eur Cytok Net. 2001;12(2):223–30.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7. doi: 10.1126/science.284.5411.143
   PubMed Web of Science ®Google Scholar
• Conforti A, Biagini S, Del Bufalo F, Sirleto P, Angioni A, Starc N et al. Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia. PloS One. 2013;8(11):e76989. doi: 10.1371/journal.pone.0076989
   PubMed Web of Science ®Google Scholar
• Mallampati S, Leng X, Ma H, Zeng J, Li J, Wang H, et al. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. Blood. 2015;125(19):2968–73. doi: 10.1182/blood-2014-05-576421
   PubMed Web of Science ®Google Scholar
• Loges S, Heil G, Bruweleit M, Schoder V, Butzal M, Fischer U, et al. Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival. J Clin Oncol. 2005;23(6):1109–17. doi: 10.1200/JCO.2005.05.058
   PubMed Web of Science ®Google Scholar
• Hou HA, Chou WC, Lin LI, Tang JL, Tseng MH, Huang CF, et al. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leuk Res. 2008;32(6):904–12. doi: 10.1016/j.leukres.2007.08.010
   PubMed Web of Science ®Google Scholar
• Hatfield KJ, Hovland R, Oyan AM, Kalland KH, Ryningen A, Gjertsen BT, et al. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia. 2008;22(2):287–93. doi: 10.1038/sj.leu.2404985
   PubMed Web of Science ®Google Scholar
• Vrbacky F, Smolej L, Vroblova V, Pekova S, Hrudkova M, Cervinka M, et al. Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features. Hematology. 2010;15(4):210–4. doi: 10.1179/102453309X12583347113898
   PubMed Web of Science ®Google Scholar
• Pappa CA, Tsirakis G, Samiotakis P, Tsigaridaki M, Alegakis A, Goulidaki N, et al. Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma. Cancer Invest. 2013;31(6):385–9. doi: 10.3109/07357907.2013.800093
   PubMed Web of Science ®Google Scholar
• Cheng CL, Hou HA, Jhuang JY, Lin CW, Chen CY, Tang JL, et al. High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes. Br J Cancer. 2011;105(7):975–82. doi: 10.1038/bjc.2011.340
   PubMed Web of Science ®Google Scholar
• Schliemann C, Bieker R, Thoennissen N, Gerss J, Liersch R, Kessler T, et al. Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia. Leukemia. 2007;21(9):1901–6. doi: 10.1038/sj.leu.2404820
   PubMed Web of Science ®Google Scholar
• Orkin SH, Look AT, Lux SE, Ginsburg D, Nathan DG. Angiogenesis. In: LC J, (eds.) Oncology of infancy and childhood 1. 1st ed. Philadelphia: Saunders Elsevier; 2009. p. 27–40.
   Google Scholar
• Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 2005;118(Pt 4):771–80. doi: 10.1242/jcs.01653
   PubMed Web of Science ®Google Scholar
• Thomas M, Felcht M, Kruse K, Kretschmer S, Deppermann C, Biesdorf A, et al. Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation. J BioChem. 2010;285(31):23842–9.
   Google Scholar
• Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401–10. doi: 10.1038/nrc1093
   PubMed Web of Science ®Google Scholar
• Szmigielska-Kaplon A, Krawczynska A, Czemerska M, Pluta A, Cebula-Obrzut B, Szmigielska K, et al. Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies. Blood Transfus. 2015;13(1):102–8.
   PubMed Web of Science ®Google Scholar
• Terai S, Fushida S, Tsukada T, Kinoshita J, Oyama K, Okamoto K, et al. Bone marrow derived “fibrocytes” contribute to tumor proliferation and fibrosis in gastric cancer. Gastric Cancer. 2015;18(2):306–13. doi: 10.1007/s10120-014-0380-0
   PubMed Web of Science ®Google Scholar
• Zhao S, Chang SL, Linderman JJ, Feng FY, Luker GD. A comprehensive analysis of CXCL12 isoforms in breast cancer. Translational Oncol. 2014 May 13. pii:S1936-5233(14)00021-7.
   Web of Science ®Google Scholar
• Mowafi F, Cagigi A, Matskova L, Bjork O, Chiodi F, Nilsson A. Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation. Pediatr Blood Cancer. 2008;50(4):812–7. doi: 10.1002/pbc.21370
   PubMed Web of Science ®Google Scholar
• Ge J, Hu Y, Gui Y, Hou R, Yang M, Zeng Q, et al. Chemotherapy-induced alteration of SDF-1/CXCR4 expression in bone marrow-derived mesenchymal stem cells from adolescents and young adults with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2014;36(8):617–23. doi: 10.1097/MPH.0000000000000220
   PubMed Web of Science ®Google Scholar
• Kollet O, Spiegel A, Peled A, Petit I, Byk T, Hershkoviz R, et al. Rapid and efficient homing of human CD34(+)CD38(−/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2 m(null) mice. Blood. 2001;97(10):3283–91. doi: 10.1182/blood.V97.10.3283
   PubMed Web of Science ®Google Scholar